Language selection

Search

Patent 1038400 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1038400
(21) Application Number: 289803
(54) English Title: 1-INDANCARBOXYLIC ACIDS
(54) French Title: ACIDES INDANECARBOXYLIQUES-1
Status: Expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 260/531.1
  • 260/472.2
  • 260/496.6
  • 260/507.6
(51) International Patent Classification (IPC):
  • C07C 51/42 (2006.01)
  • C07C 63/337 (2006.01)
  • C07C 67/48 (2006.01)
(72) Inventors :
  • JUBY, PETER F. (Not Available)
  • PARTYKA, RICHARD A. (Not Available)
  • HUDYMA, THOMAS W. (Not Available)
(73) Owners :
  • BRISTOL-MYERS SQUIBB COMPANY (United States of America)
(71) Applicants :
(74) Agent:
(74) Associate agent:
(45) Issued: 1978-09-12
(22) Filed Date:
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract






Abstract of the Disclosure
5-Cyclohexyl-1-indancarboxylic acids are useful anti-inflammatory agents
in the treatment of inflammatory diseases in animals, including man. An
example of a compound of the disclosure is 5-cyclohexyl-1-indancarboxylic
acid.


Claims

Note: Claims are shown in the official language in which they were submitted.



The embodiments of the invention in which an exclusive
property or privilege is claimed are defined as follows:


1. A process for the preparation of a substantially pure
isomer of the compound having the formula (V)




(V)
Image


in which Y is H, Cl, Br, I or F;
A is hydrogen or (lower)alkyl
and pharmaceutically acceptable salts thereof, which comprises
resolving the product of formula V occurring in the form of a
racemic mixture into a substantially pure isomer by treatment
with an optically active resolving agent and recovering the
substantially pure isomer so obtained and where required conver-
ting said substantially pure isomer into a pharmaceutically
acceptable salt thereof.




2. The process as in Claim 1 wherein the substantially
pure levorotatory isomer of the compound is obtained by
treating the compound with an appropriate optically active
resolving agent.



3. The process as in Claim 1 wherein the substantially
pure dextrorotatory isomer of the compound is obtained by
treating the compound with an appropriate optically active
resolving agent.



4. The process as in Claim 1 in which A is hydrogen.



5. The process as in Claim 1 in which Y is chloro.



6. The process as in Claim 1 in which Y is hydrogen.



7. The substantially pure levorotatory isomer of the
compound having the formula (V)

(V)

Image


in which Y is H, Cl, Br, I, or F;
A is hydrogen or (lower)alkyl and pharmaceutically acceptable
salts thereof whenever prepared by the process of Claim 2.



8. The substantially pure dextrorotatory isomer of the
compound having the formula (V)



Image (V)

31



in which Y is H, Cl, Br, I or F;
A is hydrogen or (lower)alkyl and pharmaceutically acceptable
salts thereof whenever prepared by the process of Claim 3.



9. The process of resolving a compound having the
formula

Image

in which Y is chloro
and A is hydrogen or lower alkyl
occurring in the form of a racemic mixture into its substantially
pure levorotatory (1-) isomer by treatment with an appropriate
optically active resolving agent, and recovering the substantially
pure levorotatory isomer so obtained.



10. The process of resolving a compound having the
formula



Image


in which Y is chloro
and A is hydrogen or lower alkyl
occurring in the form of a racemic mixture into its substantially
pure dextrorotatory (d-) isomer by treatment with an appropriate
optically active resolving agent, and recovering the substan-
tially pure dextrorotatory isomer so obtained.


32


11. A substantially pure isomer of the compound
having the formula




(V)
Image



in which Y is H, Cl, Br, I or F;
A is hydrogen or (lower)alkyl
and pharmaceutically acceptable salts thereof, whenever
prepared by the process of Claim 1.


33

Description

Note: Descriptions are shown in the official language in which they were submitted.


- ?

,_~

1038400
~ackground-of the Invention
~ ! `- 1. Field of the Invention:
., I --
¦ The compounds of the present invention relate to
i 5-cyclohexyl-1-indancarboxylic acids which compounds are usefulI non-steroidal anti-inflammatory agents.
2. Description of the Prior Art:
I The compounds 4-isobutylphenylacetic acid lSouth
4 African Patent 62/294 (1962, 4-isobutyl-~-methyl-phenylacetic
acid [5.S. Adams, E.E. Cliffe, B. Lessel, and J.S. Nicholson,
J. Pharm. Sci., 56, 1686 (1967)], 3-chloro-4-cyclohexyl-~- methyl-
phenyl-acetic acid [T.Y. Shen, Chim. Therap., II, 459, (1967)],
and 5-~-methoxyphenyl-2-indancarboxylic acid tM. Mlnssen - Guette,
M. Dvolaitzky, and J. Jacques, Bull Soc. Chim. France, N.5, 2111
~ (1968)~ have been described in the literature as being useful
- ~ anti-inflammatory agents.
.
Disclosure of the Invention

~hi8 inventlon relates to non-steroidal anti-
inflammatory agents useful in animals, including man, which com-
~ pounds are characterized by the formula
:~ , 20
,,

R ~ 2

in which
I R is cyclohexyl, I
¦ Y is hydrogen, bromo, chloro, iodo, fluoro, merc~pto,
cyano, hydroxy, trif~uoromethyl, (lower)alkyl, (lower)alkoxy,

~ ~

.
:,

-- -- --
i~ ~
: ~ ~

~ Q38400
nitro, amino or tlower)-alkylthio; or a nontoxic, pharmaceutically-
acceptable salt thereof. The carboxyl group in the compounds
of the instant invention is attanced to an asymmetric carbon
atom ~*) such that the compounds exist in two isomeric forms,
dextro- and levorotatory isomers. Both the substantially pure
dextro- and levorotatory isomers of these compounds, as well as
the racemic mixtures are considered to be an integral part of
the invention.
I It was an objec~ of the instant invention to prepare
non-steroidal anti-inflammatory agents that would be useful in
the treatment of a variety of inflammatory diseases such as
Theumatoid Arthritis, Rheumatoid Spondylitis, Osteoarthritis,
¦ Gout and other similar afflictions.
These objectives have been achieved by the provision
of a process for the preparation of compounds of the formula (I)
CO2A

''`. I 0/
.':' I
¦ in which A is hydrogen or lower alkyl, which comprises reducing
a compound of the formula (II)
,~ I
'' ' C02A
(II)

1 o

~ in which A has the meaning defined above, and recovering the
¦ compound of formula I so produced.

. ;
-- 2 --
. . . .

.. ! ~
. . ..

., ~031B400
j In one aspect the present invention provides such a
¦ process further comprising, when A is hydrogen, forming a nontoxic,
i pharmaceutically-acceptable salt of the compo~nd.
¦ In another aspect the invention provides the compounds
of formuLa ~I) and nontoxic, pharmaceutically-acceptable salts
thereof.
In another aspect the present invention provides a
~' process for the preparation of a compound having the formula
.: I .
C02A
~>

., .

. I wherein A is hydrogen or (lower)alkyl which comprises the follow-
¦ ing steps in sequence:
I (a) reacting a compound of the formula
.~. I
~ I ~ ~CHO

O
¦ with a malonic acid ester of the formula CH2(C02R)2, wherein R
is a (lower)alkyl radical, to produce a compound of the formula

~CH= C(C02R)
.,' I O
'' ' l . .
' wherein R has the previously recited significances;
i 30

. I ~ 3
,

l--;

0 ~
;~b) converting the compound obtained in step ~a) to a
compound having the formula

; i CN

~ ~ CH - CH2 - C02R
.' I ~
'', I V
~,,, ~ - -
' ' '.
;~ , 10wherein R is as specified above, by reaction with hydrogen cyanide
'~ ' or its salts;
...(c) hydrolyzing the compound obtained from step (b)to
~ obtain a compound of the formula
..
: C02H

.,, , ~ ~ CH2 - COOH
'' O
. . ,
(d) cyclising the compound obtained from step (c) or a
reactive derivative thereof to produce a compound of the formula

. ~ C ~H

III


(e) reducing the compound of the formula t~II) as obtained
, ~ . .
in step (d) to a compound of the formula


.
~ - 3(a) -

.,



: l . 1038400
-, C02~
~, C~ (rV)
'. :i
and recovering the product so obtained; and, in the event that
a compound within the scope of formula I, wherein A is (lower)-
I
alkyl, is desired;
(f1 e~terifying the product of step (e) above with an
. J alcohol of the formula R'O~, where R' is (lower)alkyl, and
I recovering the product so obtained.
: ¦ In one aspect, in step (d) the cyclization of the com-
` I pound obtained from step (b) is accomplished by converting the
.3 ¦ compound from step (b) to the corresponding anhydride and
reacting the anhydride with aluminum chloride in the presence
t ~ of methylene chloride to produce the compound of formula III.
I i The compound of formula II may preferablybe reduced by means
.~ I of catalytic hydrogenation.
~ i 20 In a further aspect the present invention provides
I , a process for the preparation of compounds having the formula
! (IV)
:.~ ' C2A :


'

; I in which Y ls halogen
and A is hydrogen, a (lower)alkyl radical or (lower)alkyl
radical possessing a t-amine function and pharmaceutically
:
~ - 3(b) -

. I

,

C~
, ~
acceptable ~lts thereof, which comprises halogenating a
i compound having the formula

: I C02A
0~
in which A has the meaning defined above,
or a salt or a functionally converted derivative thereof; and
where required converting the functionally converted derivative
into the compound of formula (IV) wherein A has the mean?ng
, defined above; and where required converting any free acid of
.; . the formula (IV) so produced to a pharmaceutically acceptable
salt thereof.
; In still another aspect the invention provides a
process for the preparation of a substantially pure isomer of
- ~ the compound having the formula (V)

. . . .
: ¦ C()2A
C ~ (V)

, '~
I in which Y is H,'Cl, Br, I or F;
A is hydrogen or (lower)alkyl
and pharmaceutically acceptable salts thereof, which comprises
I resolving the product of formula V occurring in the form of a
~ racemic mixture into a substantially pure isomer by treatment
I with an optically active resolving agent and recovering the
', 30 substantially pure isomer so obtained and where required
, converting said substantially pure isomer into a pharmaceutically acceptable salt thereof.

- 3(c)

... . .. . . . ..... . . .


~ i!
Ill 1(138~W~ ~

1 1l The pharm~ceutically-acceptable, nontoxic cations include metallic
j
2 !' cations such as sodium~ potassium, calcium and stluminum and orgs~nic amine
3 ¦I cations of trl~lxylamines~ e.g. triethylamine, procaine, dibenzylamine,
4 il ~-benzyl-~-phenethylE~ine, l-ephenamine, N~'-dibenzylethylenediamine,
S ¦¦ dehydroabietylamine, N,N'-bis-dehydroabietylethylenediamine, ~-(lower)-
¦l alkyl-piperidines, e.g. N-ethylpiperidine, and other amines which ha~e
7 1~ been used tc form salts with medicinally acti~e carboxylic acids.
S 1I me ter~ "tlower)alkyl" as used herein means both straight and
9 ¦I branched chain aliphAtic hydrocarbon r~icals ha~ing from 1 to 6 carbon¦1 atoms such as methyl, ethyl, propyl, isopropyl, butyl, iæobutyl, etc.
11 ¦ Simi~arly, whc~e the term "(lower)~' is used as part of the tescription of
another group~ e.g. "(lower)alkoxy", it refers to the alkyl portion o~
13 1¦ such group whlch is there~ore as described abo~e in connect_on w1th
~t 1l "(lower)aikyl" and thus lncludes such radicals as methoxy, ethoxy, lsopropoxy,
¦ etc.
16 ll me compoun,ds o~ the instant ~n~ention can ~te prepared by the
!l ~oll~wing s~
1, ~C~IO ~ HOAc ~C~ C~C2C2~5)2
~ ~ ~ OH2(C02C2}~5)2

22 j C02~ ~ CN

23 1 ~ *CX~c~~c02~ ~ *CH-Ç~2C02c2x5
24 1 ~ ~HCl

26

28 ~ , AlC13

30 ~¦B ~ ~2 B~l~\ ~ I~HOAO/XC104


1; ~

- :
;: :

10384~0
; wherein R is cyclohex~l.
The optionally Y-substituted 5-cyclohexyl-1-indancarboxy-
lic acids of the present invention can be prepared by one of two
synthetic routes:
1. (a) 6-Halosubstituted-l-Indancarboxylic Acid:
5-Cyclohexyl-l-indancarboxylic acid is halogenated
with N-halosuccinimide to produce 6-halo-5-cyclohexyl-1-indancar-

;~ boxylic acids (see Example 3).
(b) 4 or 6-Nitrosubstituted-l-Indancarboxylic Acids:
5-Cyclohexyl-l-indancarboxylic acid is nitrated

with one equivalent of nitric acid in the presence of sulfuric

:; acid to produce a mixture of 4 and 6-nitro-5-cyclohexyl-1-indan-
carboxylic acids. The mixture can be resolved into pure 4-nitro-
5-cyclohexyl-1-indancarboxylic acid and 6-nitro-5-cyclohexyl-1-
indancarboxylic acid by methods known to the art. These resolved
6-nitrosubstituted compounds are most valuable as intermediates
in the preparation of the other claimed compounds of the present

r'. invention.
(c) 6-Aminosubstituted-l-Indancarboxylic Acids:
; The purified 6-nitrosubstituted indancarboxylic
.
;~ acids obtained in part "(b)" above are reduced by the use of
hydrogen and catalyst (Pd/C, PtO2, etc.) to produce the 6-amino-
substituted indancarboxylic acids of the present invention.
- (d) l-Indancarboxylic Acid Diazonium Salts:
The aminosubstituted compound prepared in step
"(c)" above is placed in a strong mineral acid, i.e., HCl, H2S04,
HBr, etc., at 0 C. Nitrous acid is generated in situ by the

addition of sodium nitrite to produce the diazonium salt of the
amine.

(e) 6-Hydroxy-5-Cyclohexyl-l-Indancarboxylic Acid:
Heating of the 6-diazonium salt obtained in step

~(d) n after the addition of water, will result in the formation
` of the 6-hydroxy-5-
-- 5 --

,
"' ' - : ; '' '~ ' : `';



11 1038~
1 `1 cyclohexyl-l-indancarboxylic acid.

(f) 6-Alkoxy-5-Cyclohexyl-l-Indancarboxylic Acid:
j,
3 ~' Heating of the 6-diazonium salt obtained ln step "(d)" after
the additlon of the appropriate alcohol will result in the formation of the
5 1 6-~lkoxy compound.
6 ,l (g) 6-Halo-5-Cyclohexyl-l-Indancarbox~lic Acid:
; The 6-diazonium salt prepared as in Step "(d)" ~rom the
3 ll 6-sminosubstltuted-l-lndancarboxylic acld obtained in step "(c)" ls
g j, tre~ted with either cooper-bronze (Gattermann Reaction) or cuprous hal~de

~l (Cl, Br~ I) to produce the 6-halosubstituted compound.
(h) 6-Cyano-5 Cyclohexyl-l-Indancarboxyllc Acid:

`' 12 1I The 6-dia~onium salt obtained by the procedure o~ step "(d)"
~ which 18 prepared in ~ S ~ ls treated with base to neutralize the salt
-~ 14 ,li solutlon, followed by the addltion of a solution o~ cuprous cyanide-sodium
` It
:~ 15 Ij cyanlde complex to produce a preclpitate. He~ting Or the prec~pitate

16 !i decomposes it to the cya~osubstituted acid.
7 ¦¦ (i) 6-Fluoro-6-CyclohexYl-l-IndancarboxYlic Acid:

l8 ~¦ The 6-di~zonium salt, as in step "(g)", is treated with

~ Ij fluoroboric acid~ The fluoroborate precipitates and is collected. After

¦ washing and drying~ the precipltate is heated and it d~composes ~o ~hc
~ deslred 6-~luorosubstltuted compound.
22 1l (J ) -Merc~pto-5-~yclohexyl-l-Indancarbox~lic acid: l
23 ll The 6-dia~onlu~ salt prepared in step "(d)" is treated with

24 jl potassium ethyl xanthate which produces an ethyl dlthiocarbonate. Saponiri~ i


2S l¦ cation of the dithiocarbonate produces t~e des~red 6-mercaptosubstituted

26 ¦¦ co~pound

27 ll ~k) 6-Methylthio-5-Cyclohexyl-l-Indancarboxylic acid:

Il Treatment o~ the 6-mercaptosubstituted c~mpound obtained in

29 1 step "(J)" with dimethYlsulfate in the presence of a base~;followed by mild

il hydrolysis, produces the 6-methylthiosub~tituted a¢id.
11 ' ~'''' ), ' ~
-6- I


!
` 10384~0
1 " ~1) 6-Methyl-5-Cyclohexyl-l-Indancarb x~ic Acid:
2 !, The 6-bromo- or iodo~5-cyclohexyl-1-indancarboxylic acid
3 obtained in Step "(g)" is treated with lithium dimethylcopper to produce
6-methyl-5-cyclohexyl-1-indancarboxylic acid [E.J. Corey and G.~. Posner,
S , J. Am. Chem. Soc., 89, p. 3911 (1967)].
6 ,~ me compounds of the instant invention can be prepsred by the
utillzation of one or more o~ the disclosed procedures above and they
,l include among others:

il 6-Chloro-5-cyclohexyl-1-indancarboxylic acid,
10 l,l 6-~romo-5-cyclohexyl-1-indancarboxylic acid,
11 1' 6-Iodo-5-cyclohexyl-1-indancarboxylic acid,
12 jl, 6-Fluoro-5-cyclohexyl-1-indancarboxylic acid,
13 ' 6-Hydroxy-5-cyclohexyl-1-indancarboxylic acid,
14 ! 6-Methoxy-5-cyclohexyl-1-indancarboxyllc acid,
lS I 6-Nitro-5-cyclohexyl-1-indancarboxylic acid,
6-Amino-5-cyclohexyl-1-indancarboxylic acid,
1~ 6-Cyano-5-cyclohexyl-1-indancarboxylic acid,
18 ~l 6-Methy1-5-cyclohexyl-1-indancarboxylic acid,
19 !1 6-Mercapto-5-cyclohexyl-1-lndancarboxylic acld~ and
20 i1 6-Methylthio-5-cyclohexyl-1-indancarboxylic acld.
21 ¦I m e cc~pounds Or the instant invention can be resolved into their
22 l¦ substantially pure dextro- and levorotatory ~somers by ~ethods co = nly
23 1l known ln the art. ~or illustrative purposes, the compound 5-cyclo-
24 1l hexyl-l-indancarboxylic acid wa6 resolved into its respective lsomers by
1 the procedure of ~irst treatlne the mixture with cinchonidine to produce the ¦
26 1 cinchonid1ne salt Or (~)-5-cyclohexyl-1-indancarboxylic acid. The salt
27 ¦I was recrystallized and then decomposed to the Sree ~cid to yield
28 ~! substantially pure (~)-50cyclohexy1-l-indancarboxylic acid.
2g 11 The levorotatory acld enriched mother liquor6 remain~ng above, a~ter
ll the collectlon of the clnc~onldine salt o~ the dextrorotatory acld wss


!1 ~ ; _7_ I ,i
I!

.


., 11 , ., .
,1 1038400
1 1, isolated fro~ it, was concentrated to dryness. The resldue was treated
` ¦¦ with ether and hydrochlorlc acid. A partially resol~ed mixture o~ the
3 ,I dextrorotatory and levorotatory isomers, enriched with the levorotatory
4 ~¦ acid, was obtsined
S 'l me enriched acid was d~issolved in ethanol and treQted with dehydro-
6 ¦I abietyla~ine. The dehydroabietylamine salt of (-)-5-cyclohexyl-1-
~ 7 j~ indancarboxylic acid was collected and purified by crystalllzation. The
- ~ 1l 6alt was treated with hydrochloric acid, and extracted with ether. The
9 ¦~ ethereal solution was concentrated to dryness and substantially pure
1 10 11 levorotatory isomer crystallized from petroleum ether. (See Example 4.)
All the compounds of the instant invention can be resolved into
12 ¦ their component dextrorotatory and levorota~ory isomers by a procedure
13 ¦ similar, if not identical, to that described above. ~xaimination of the
14 ¦ chemic~l literature likewise provides many other methods for the resolution
¦ of racemlc monocarboxylic acid~.
Some racemic mixtures can be precipitated as eutectics instead o~
17 ¦ mixed cr~stals and can thus be ~uickly separated and in such cases can
18 ¦ someti~es be selectiVe~Y precipitated. me more common method o~ chemicsl
~ resolution may be used. ~y this method diastereomers are formed from the
- 20 ¦ racemic mlxture by rew t~on with an opticall~v-active ~e~olYing agent. mus~
21 an optically-actl~e base can be reacted with the carbox~l group. The
22 difrerence i~ solubility between the diastereomer~ ~ormed permits the
23 ¦ selective cryst~llization of one form and regeneration o~ the optically-
24 '¦ active acid ~ro~ the mixture. Ihere ls, however, a third method of
~ resol~ing which shcws great prcmise. This is one of the other ~orms of
26 biochemical procedu~es using selecti~e e~zymatic reaction. Thus, the
27 -racemic acid can be sub~ected to an asym~etric oxidase or decarboxylase
28 whlch w~ by oxldatlon or decarboxylation~ destroy one ~orm, leaving the
29 other form unchanged. EYen more a~tractiYe i8 the use Or hydrolylase on

¦¦ a derivati~e Or the racemic ~ixture to form preferentially one ~orm of
. 11 , , , . ~ , .
'8~
.
.. _. _ _.. _._ .. _,._,_. _ , _ ! '

Ij



the acid. Thus, esters or amides o~ the acids can be sub~ected to an
~ jl esterase which will selectlvely saponify one enantiomorph and leave the
3 11 other unchanged. Amide or salt diastereomers of the free acld may be
4 1l ~ormed with optically-active amines, such as quinine, brucine, cinchonidine,
S 1l cinchonine, dehydroabietylamine, hydroxy-hydrindamlnej menthylamine,
6 l' morphine, ~-phenylethylamine, phenyloxynaphthylmethyla~ine, quinldine,
7 i~ l-renchylamine, strychnine, basic amino acids,-such as ly6ine, arginine,
3 l; amino acid esters, and the like. Similarly, ester diastereomers of the
g !i ~ree acid may be formed with optically- active alcohols, ~uch as borneol,
1~ menthol, 2-octanol and the like. EspeciaIly preferred is the use of
~ cinchonidine to eive the readily decomposable diastereomer salt which
12 ¦I may then be resolved by dissolving in a solvent, such G8 acetone, and
13 ¦¦ d$stll~ng the solvent at atmosphcric ~ressure unt~ cryst~ls begin to
14 ~¦ appear and further crystallization produced Oy allowing the mixture to
l! cool to roo~ temperature, thereby separating the two enantiomorphs.
16 il me acid m~y then be recovered from the s~lt by extractine the s~lt between j
17 ¦1 an organic solvent, such as petroleum ether and dilute hydrochloric acid
18 11 or ~o~e other organlc solvent agueous system. Worhup of the rem~ining
9 li mother liguors and subsequent puri~ica~ion will ueually provide the other
20 ¦¦ isomer. 'I
21 1! It i~ noted~ however, the racemic mixtures themselves are potent
22 !1 anti-inflam~a~orY ugents.
23 1! The compounds o~ tkis in~ention h~ve a high degree o~ anti-~nflamm~tory !
24 ¦¦ actlvity.They are useful in treating arthrit~s, rheum~tism and other
2S 1¦ inflammatory diseases in ma~$als.
26 ~! Anti-inPlamm~tory te3ts o~ the compounds o~ the ~resent invention
27 jl were carried out on rats using the carrageenln-induced ~oot edema test28 ¦ Or Charles A. W~n~er et al., "Carr~geenin-I~duced Edema i~ Xind Paw o~ th~
29 li Rnk a8 an A~say ~or Anti-In~lamm&tory Drug5~ Proceedings of the Soclety
1I for Experi~ental Biology and M~dlcine~ 111, 544 (1962). me co~pound


Il !



. 103~400 .
1 li under inve~tigation W&~ given orally to the rat, and one hour later
2 ¦I c8rrageenin was in~ected subcutaneously into one p8W- Three hours later3 ,I the degree of ede~a was measured volumetrically by fluid displacement, '~
, and compared to that of the control paw to give a result presented
S I in term~ of percentage inhibition of edema. Any result of more than 30
6 i.¦ inhibition was greater than three t~mes the standard deviation of the
result in control animals, and thus clearly indicated anti-i~flammatory
S I activlty.
9 ¦ In the rat paw edem~ test described above, the compounds o~ the
1 instant invention exhibit anti-inflammatory activ$ty deemed use~ul in the
11 ~ treatment of in~lammatory diseases in mammals, including man. The
12 1 co~pounds of the invention are gener~lly use~ul in the dosage range of
13 1 about 0.1 mg./kg. to about 40 mg./kg. three to four ti~es a day.
14 T~ey can be administered orally or parenterally, but preferably
~ 1 or~lly. More specifically, the co~pounds of the inst~nt invention are
16 l preferentialiy adm~nlstered in dosages in the range of about 0.2 mg./kg.
17 1 to about 30 mg./kg. three to four times a day.
18 ll The dosage wlll vary with the particular compound of the in ention.
~ jj For ex~pla~ 5-cyclo~exy~ indancarbcxylic scid produced a 61~ inhibltion
20 ¦ ~ edem~ at a dose of 128 mg./~g. Its minimum effectl~e dose (MED) was
21 ¦ 3,7 mg./Xg. (MED is de~ined as the dose which produces 30% inhibition
22 ¦ o~ ~dema) and its lethal dose in 5 ~ o~ the animal~ (LD50) wa6 287 mg /Xg
23 ¦ m e therapeutlc lndex was 76.
24 ¦ (l)-6-Chloro-5-cyclohexyl-1-lndancarboxylic acid hcwever, was
substantially more potent in producing a 62~ inhibltion oP edema at 128 mg./
26 kg., with an MED of 1.5 mg./kg., and LD50 o~ 41 ~g.jkg. and a th~rspeutic
27 index o~ 27.
28 Resolution o~ 6-chloro-5-cyclohexyl-1-lndancarboxylic scid into
29 ¦ it~ (+) and (-) isomers showed that the dextr~rotatory (1) isomer was the
` re potent haYing an MæD of 0.85 mg./kg. as compared to-the levorotatory
.. ' : '' '' `) ' "
I , . `` -10- ' ` ' `
`: ! . . I

;; , ~' ~ . _ ~ _



~(~3fl400
I 11 isomer which h~d an MED of 16 ~g./kg.
~ 11 In the case of 5 cyclohexy}-l-indancarboxylic acid, it ~ppears the
3 l! m~ority of the anti-lnflammatory activity resides in the levorotatory
1, 1 isomer, (-)-5-cyclohexyl~l-indancar~,oxylic acid, as compared to little
S ,~ or none in the dextrorotatory isomer. The unresolved racemic mixture
Il 16 ~cti~e a6 ouch however and is useful as an anti-inflammatory agent.
7 t,l The oral dosage in humans o~ the comFounds of the present $nventio~8 is in the range o~ about 0.2 mg./kg. to about 25 mg./kg. administered
9 three or four times a day. The preferred human dosage is in the range
0.2 ~g.tkg. to about 10 mg./Xg. three to four times a day.
11 j The carboxylic acids I of the present in~ention have also ~hown
12 11 actl~ity in Dice, rats and dogs when administered in the ~orm of their
(lower)alkyl esters or terti~ry-amino (lower)alXyl esters. mese compounds
14 ¦ are also considered an integral part of the present in~ention.
~ I Ihere~ore, a preferred embodim~,nt o~ the present ln~e~tion are the
16 ¦ compounds havin~ the r~rmula
17 y~




23 Y iB hydroger., chloro, bromo, ~luoro, hydroxy, (lower)alkyl, (lower)~lXoxy,24 mercapto, cyano~ nitro~ amino or (lower)~lkyithio, ~5 is (lower)alkyl or
2S a (lower)alkyl posses6ing a ~amine function; or a pharmaceutically
2~ scceptRble salt thereof.
Another pre~erred embod$ment are the compounds ha~ing the ~ormula
28.! .. , I
29 11, . ' . ' ' I
30 1l ~



... ... . ... . ....... .. . ... ..
.. , . . , . .... ..... , .. , ., . . ... . , . ., , = . .... .

_ ._ . ~ .. _ . _ _. . __ _ _~.. . ~ . _ . . .~ ._~ ___ _ _ _ ._ : ~ ' . : . .~ :.. ___A _ _ _ ' _ . _ _ _:_ _ . . _ .

,
_- .

'I ' ' _
: , ~038400
1 ' - Y O R5

2 , - ~
. ., ', , , lJ . ' , .
S
6 '' in wh1ch
Y i~ hydrogen, chloro, ~luoro, hydroxy, (lower)alXyl, (lower)alkoxy, n~tro
8 ll or amino, R5 i6 (lower) alkyl or a (lower3alkyl group possesi3ing a t-amine9 ~i ~unctlon; or a phArmaceutically acceptable ~alt thereo~. I
,, Another preferred e~bodiment are the co~pounds ha~ing the formula
11 i1
2 ~ C02~5
lS !l
!l in which
; 17 1~ Y is hydrogen or chloro ~nd R~ is (lower)alkyl.
8 !i A more preferred embodi~ent are the compounds h~ing the ~or~ula
. 19 ii '
~o ~ c5~5



24 j~ in whieh
25 li Y i8 hydrogen or chloro and R5 is methyl, ethyl or prop~l.
For the purpo~e of thi3 disclosure~ the term "(lcwer)alkyl po9sess$ng
27 ¦ -a t a~ine runctlon" shail mean a group consisting of up to 8 c~rbon atoms,
28 j which ~roup conta~n~ a t-~mlne funct~on, i.e., NjN-dimethylaminoethyl~,
29 j N,N-diethylsninoethyl-, N-methyl-4-piperidyl-, N-et~yl-4-pyrrolidyl-,
30 ¦¦ N-mRthyl-3-pyrrolidyl-, ~,N-dimethylaminoprop~l-, or the like.

!l !
..

.j ~

- 103~400
.. ,, . i .
1 ~ ~en the compounds of the present invention contain an ester function
2 ,I possessing a tertiary amine ~unction, the compounds are capable o~ forming3 ~cid addition salts such as the hydrochloride, hydrobromide, hydroiodide,
.
- 4 j sulf~te, sulf3mate, and phosphate~ and the organic acid additlon salts
- S ~I such as the maleate, acetate, citrate, succinate, benzoate, tartrate,
., . ,; . , .
6 . malate,.~andelate, ascorbate and the like. All o~ these salts and their
7 1l equivslents sre a part o~ the invention.
jl , , ., ' ' .. i,

:~ . 9 '
.~ " 1' ,
10i'
: 11 !i - '... .- I `
.. 12 ,!
13 Ij
14. ' .
' ~ 1 1 . . , . . , , - . ,
` lS,i " ,......... . ...
.. 16., . :
~ . 17 1i - ~ '

19 )~
;; . 20 !1
-~ 211 ' . .
.. ~ ; , ,, , : . . .
221 . - '.
23
: 24,!

2S111 ' ', ' " ' ' ' ' ,. " ' ' ~ ' '
'!; ' 26 !i
27
.,, . ~l . .

28 ,~
29 ll
30 !1 -
1~ , . ...
!
~ 3-
',1 , ' . , .

- - -
.` .


.. ~ '.~ ,. . .
.. 1l , '. ' 1031B400
1 1IDescriPtion of The Preferred Em odiments
2 . i
' 'l( ample 1
3 li '~
4 ~ A) p-Cyclohexylbenzaldeh~de: ~D. Bodroux and R. Thomassin, ComPt. 'i
R~ 205, 991 (1937
. S ,~
6 Il Titænium tetrachloride ~A. Rieche, X. Gross, and E. Hoft, Organic
7 ¦I Syntheses, 4I, 1 (1967)] (183 ml., 316 grams, 1.67 moles) was added
~ 8 ~1 ~lcwly o~er a period of ten minutes and with constant stirring to a
: 9' ¦I cooled'(ice-water) solution of cyclohexylbenzene (160 grams, 1.0 mole)
! ~ in methylene chloride (650 ml.). With continued stirriag and cooling,
~ dichloromethyl methyi ether (96 gra~s, 0.833 mole) was added dropwise '
-- 12 1 over ~ period o~ 45 mi~utes. After the addition was complete, the mixture
was ~tirred for thirty minutes with cooling, ~ol}owed by 130 mlnutes at
14 ¦¦ room temperature. The reaction ~ixture was poured onto ice. The orga~ic
lS ! layer W~8 separated and the aqueous layer extracted with methylene chloride ~,
16 il ~3 x 250 ml.). me comb~ned methyler.e chloride solution was washed with
17 ¦I water (2 x 400 ml.) and drled (sodium sul~ate). The dried solution was
reduced to dryness in a rotary e~porator to lea~e a brcwn oil (209 grams).
me oil ~as di~tilled under reduced pressu~e. ~-Cyclohexylbenzaldehyde
l (81.3 grams~ 52%) was collected ag the fraction with bp 9ô - 100/0.2 ~m
' 21 ~lit. D. Bodroux and B. mo~ass1n~ ~ .'Rend.~ ?05, 9g~ (1937) ~ bp 159
'' 22 10 ~.] ' ' , ' ' : ' 1'
23 ~
"...................................... : ' : ' ' ., 1,
' 24 3) Diethyl ~ clohex~lbenzylidenemalonate.
"'' 2S . , '" ': . I
' ' 26 A solution o~ ~-cyclohexylbenzaldehyde (9.4 grams, 0.05 mole)9
27 dlethyl malonate (8.01 gra~s, 0.05 mole)~ piperidina (0.5 gram), ~nd
~ 28 glacial acetlc acid (0.33 gram) in benzene (25 ml.) was heated under reflux
- ¦ for 18 hours ~C.F.H. Allen ~nd F.W. Spangler~ "Organ1c 8yntheses~" Coll.

30 j Vo~. III, John W11 y and Sons, I~c.~ New York~ ~ew Yor~ 1963, p. 377].

" ' ' -14~
Il ' , ,,'' ' ' ' I

The liberated water was removed from the reaction mixture as it was ~ormed.
The cooled reaction mixture was diluted with benzene (25 ml.), washed with
wa~er (2 x 25 ml.) followed by 1 N hydrochloric acid (25 ml.), water
(25 ml.),saturated sodium bicarbonate solution (25 ml.), and water (25 ml.).
The solution wa~ dried (sodium sulfate) and concentrated in a rotary evspora-
tor to leave a yellow oil (17.7 g.). The product was distilled under
~acuum. Diethyl ~-cyclohexylben~ylidenemalona~e (11.7 grams, 71%) was
collected as the fraction with b.p. 172 - 174°/0.01 mm.
nal. calc'd. ~or C2oH2604: C, 72-70; H~ 7.93.
Found: C, 72.62; H, 7.94.



C) Eth~l 3-Cyano-3~ c~clohex~l~henyl ~roPionate


A solution Or potas6ium cyanide (l.ô grams, 0.0277 mole) in water
(4.5 ml.) wa6 added quickly to a solution of diethyl ~-cyclohexylbenzyli-
denemalonate (9.0 grsms. O.oe72 mole) in 10~ ethanol (90 ml.). The
stlrred mixture was heated by means of an oil bath maintained ~t about
70° ~or twenty hours tC.F.H. Allen and H.B. Johnson, "Crganic Syntheses,"
Coll, VR1~ IV, John Wiley and Sons, Inc., ~ew York, New York, 1963,
p. 804]. The reactlon ~ixture was nlio~led to cool to roo~ tem~erature.
$he preclpitated solid was removed by filtratlon. The ~iltrate w2s
acidi~ied with 10% hydrochlorlc acid (1.5 ml.) and then concentr~ted ln a
rotary eYapor~tor. The residue was ~artit~oned between chloro~`~rm
(150 ml.) snd water (50 ml.). me chloro~orm layer was separ~ted, dried
(~odlu~ ~ul~ate) snd concentrated to l~a~e a pale yellow oil (8.1 gr~ms)
which was distilled under reduced pressure. Etbyl 3-cy~no-3-(~-cyclo-
hexylphenyl)propionate (4.2 gran~, 54%) was collected as the ~rsction
w~th b.p. 160 - 161-¦0.15 mm.
An~l. Calc'd ~or C18H23N02:~C, 75-75; H~ 8.12
Found: C~ ?5~77; H, 8.28



l i
49~
1 1' D) P-cyclohexylphenylsuccinic Acid
2 !l .
3 1~ A mixture o~ ethyl 3-cyano-3-(~-cyclohexylphenyl)-propionate ~3.0
I¦ grams), gl&CiBl acetic acid (10 ml.) and concentrated hydrochloric acid
S i¦ (10 ml.) was heated under reflux for three hours. A cry~talline solid
; ,, separated ~rom the re~ction mixture which W85 allowed to cool 810wl~.
1¦ The solid (1.95 grams, 67~), with m.p. 178 - 182, was recrystallized from
- I! aqueous eth~nol ~ollowed by ethyl scetate to gi~e the p-cyclohexylphenyl-
i! succinic acid as colorless crystals, m.p. 188 - 189~C.

1¦ - 16 20 4 ' 9 ; ~ 7 3
11 I Found: C, 6g.54; ~, 7.36
12 !i ~
il E) p-Cyclohexylphenylsuccinic Anhydride -
: 13 ~l -
.' !! . . I
14 ll A mixture of ~-cyclohexylphenylsuccinic acid (10~0 grams) and acetic
` 15 ~! anhydride t50 ~1.) was heated under re~lux for 1.25 hours. The cooled
16 ~¦ solution was reduced to dryness in a rotary evaporator and the solid
17 ¦¦ resldue rec7ystallized from cyclohexane to giYe ~-cyclohexylphenylsuccin~c
18 1¦ ~nhydrlde (8.8 grams, 94%) as colorless crystal6, m.p. 116.5 - 118C. The
~ ¦I product was recrystallized fro~ cyclohexane to gi~e colorlees crystals,
lm.~ 118.5C. I
21 ¦Anal. Cal¢ d- ~or C16H1803 C, 74.39; H~ 7-oe

!~Found: C~ 74.58; H, 7.24
23
24 F) (+)5-Cyclohex~ Loxo-l-indancarboxy}~c-Acid~ !
I -
26
C ~ K




-16-
, !l
,


l i

I1 1038gOO
'! A solu-tlon of ~-cyclohexylphenylsuccinic anhydride (33.0 grams,
2 ll 0.128 mole) ~n dry methylene chloride (400 ml.) was added dropwise to a
; 1i stirred, cooled (ice-water) suspension of aluminum chloride (37.4 grams,
4 ~l 0.281 ~ole) in methylene chloride (400 ml.) ~H.O. House, F.J. S~uter,
S ¦¦ W.G. Xenyon~ and J. J. Riehl, J. Org. Chem., 33,'957 tl968)].
6 Il, The mixture was stirred with cooling for one hour, and was then
7 ¦I sti~red at roo~ temperature for twenty-Pour hours. The'reaction mixture
¦, was reduced to dryness and the residue triturated with ice-water (500 ml.)
9 1¦ and concentrated hydrochloric acid (30 ml.). ~he resulting'gummy
'i suspension was stirred for thirty~six hours at room te~per~ture. The
mixture was Piltered asd the collected of~-white solid dried under
12 !¦ ~acuum. me solid was recrystallized from cyclohexane to give (~ 5-cyclo-
!I hexyl-3-oxo-1-indancarboxylic acid (30.4 g.,92%) as o~-white crystals,
14 !j m.p. 117-118C. A portion of the product was recrystallized (with
charcoal tre~tment) Prom cyclohexane to gi~e colorless crystals, m.p.
16 11 117 - 118C. 'l, '
7 1! Ana1- Calc'd- for C16~83 C~ 74-39; H~ 7-02 I ;'
18 ~1 Found:' C~ 74.29; H, 7.23 '
:9 !¦
G) (~)5-C~clohexyl-l-indanc~rboxylic Acid.
21

D I ~



17 ~ A solut~ Or (~)-S-oyclc~xyl-3-cxo-1-i~d~co~rooxyllc ~cic (9.0 e~G~s) i~
28 glaclal acetic acid (150 ml.) containlng 6 ~ perchloric acld (2 ml.) and
29 10~ pslladium on csrbon (2.0 grams) was shaken with hydrogen ~Parr' I
Il hydro~enator~ 3 atmo8 ) unti} no further hydrogen was ~bso~ed me

! ' ' . I
I -17- ' I
, I . " ' ' ' ~.,



1400

mixture was filtered and anhydrous sodium acetate (2.5 grams) was added
2 !~ to the filtrate. The resultin~ solution was reduced to dryness. Several
3 i~ portionæ of toluene were added to the residue and a~ter each ~ddition
. ,j , .
4 1i t~e mixture was evaporated. The residue was partitioned between diethyl
S 1~ ether (200 ml.) and water (~0 ml.). The ether layer was washed with
6 ll water (40 ml.) followed by saturated aqueous sodium chloride (40 ml.),
7 !1 and dried (sodium sulfate). The solution was ~educed to dryness to yield
Il a buff solld which was recrystallized fro~ Skellysolve ~ to give(t)-5-cyclo-
9 1I hexyl-l-indancarboxylic acid (8.4 grams, 98.5~) as bufD cxystals, m.p.
'I 145 - 147C. A portion of the product was recrystalli~ed ~rom ~kellysol~e R,
(essentially n-hexane, b.p. 60 - 68C), with cbarcoal treatment, to gi~e , -
2 ¦¦ colorless crystals, m.p. 147 - 148C.
13 ~¦ nal. Calc'd. for C16H2002: C, 78-65; X, 8-25

: 14 i~ Found: C, 78.58; H, 8.34
,., lS 111 ' '' ' '' " ' ' I
16 !
17 1 anrple 2
. , jl . !
2~ !~ Sodium 5-CYclohexyl~l-indancarbo~ylate (-) racemic mixture
21
22 ¦1 A solution o~ sodium 2-etkylhexanoate (6.15 grams, 0.037 mole) in

23 ¦ acetone (30 ml.) was add~d to a ~olution of(~)-5-cyclohexyl-1-indancarboxyli4
24 ¦ acid (9.0 grams, 0.03~3 mole) in warm acetone (70 ml.). me mixture
I was allowed to stand ~nd cool to room temperature. me crystalline solid
26 I (7.25 grams, 74%) that formed was collected, washed with acetone and I -
27 I recrystall~zed from methanol-acetone to giYe sodlum 5-cyclohexyl~
28 I indancarboxylate as colorless çrystals.
l Anal. Calo'd. for C16~ g~a02: C, 72.16; H, 7-19
-~ 30 Found: C, 72.11; ~, 7.40
* "Skellysolve B" is a trademark designating.a highly refined petroleum
. I hydrocarbon fraction with IQW evaporat.ion residue and having a specific
~ I gravity(60F) of 0. 683; a flash point of -25F; an aniline point Of 142. 5FI
: .......... ¦ and a boiling range of from 146 F to 156F.
. I . -18- i - _

.. . . . . .. . . . ..

~ l i


~l ~038l~0
!~
.'.' ' lj ' ' ' . ' ' .
Exismple ~
2 !~
; . ~
4 1 ~+)-6-Chloro-5-cyclohexyl-1-indanc~rbox~lic acid
~j
6 il N-Chlorosuccinimide (8.2 grams, 0.0614 mole) was added to a stirred,
!i cooled (ice-w~ter) solution of (f)-5-cyclohexyl-1-indancarboxylic acid (10.0
grams 0 0409 le) in dimethylformamide (82 ml ) ~he solution was
¦¦ st~rred f~r fi~teen minutes at 0C., thirty mlnutes at 25C., nine hours
il at 50C. ~ollowed by eight hours at 25C. The solution was diluted with
11 cold water (400 ml.) and stirred until the precipitated product turned

12 1I granular (fifteen minute)- The crude produc~ was collected, washed with3 ¦I cold water, and dried. Crystallization fram SXéllyæol~e B witA chQrco,~l j

14 ~¦ treatment ga~e colorless crystPls (6.65 grams, 58%), m.p. 149 - 150C. ~ ;
I . ~.
The product ~a~c recrystallized twice from Skellysol~e B to gi~e (+)-6-chloro-~
16 i 5-cyclohexyl-1-indancarboxylic acid &æ colorle6s crystals, m.p. 150.5 -
1~ 1 152.5C.
18 ~Anal. Calc'd. for C16~ 9C102: C, 68.94; ~, 6-87; Cl, 12-72
Found: C, 69.19; ~, 7.04; Cl, 12.97
20 li . ;
21
22 ¦¦ . Exam~le 4 ~ j -

23 il .
24
2S !I Resolutlion of (+)-5~Cyclohexyl-l-indancarboxylic Acid: -
26 1¦ A) (+~-5-CyclOhexy~ nd,3~ ~rbo~s~lic Acid:
27 1 ' . ~
28 ¦ A solution of (+)-5-cyclohe~yl-1-indancarboxyllc acid (15.0 grams,
¦ 0.0614 mole) and cinchonidine (9.05 granLC, 0.0307 molej in abæolute

ethL~ol (700 ~ ~ 09 boiled do;* to ~ volume Or Lbout 300 al Dhe
. I . '-19- ',
. ., . ,. I
: ~ f . i

`:


i,
03~400

1 ~ mixture was allowed to cool slowly and was left ~or twenty hours at 25C.
2 il The colorless crystals were collected and washed with cold ethanol to gi~e
3 ~! the cinchonidine sAlt o~ 5-cyclohexyl-l-indancarboxylic acid (13.0
~ ~I gram~), m.p. 212 - 212.5C. Additional cinchonidine (1.0 grsm, 0.0034
S ~ ~ole) was added to the mother liquors and thelr ~olume reduced to about
6 l, 165 ~1. by bo~ing. The hot solution was seeded w~th the salt o~ the (i)
7 1¦ scid ~nd stored at 5C. ~or sixty-fi~e hours, when an sddition~l crop
8 Ij (2.4 grams) of theicinchonidine salt of the (~) aGid, m.p. 211 - 215DC.
9 ¦1 was obtained. Th~ mother liguors were retained for isoltation of the (-)
1l isomer.
Ihe sPlt with m.p. 212 - 212.5C. was recrystallized ~rom ethanol to
12 l gi~e colorless crystnls (11.8 grams), m.p. 217.5 - 219C. The product was
partitioned between ether (500 ml.) and 10% aqueous hydrochloric acid
14 l (250 ml.). The ethereul layer was washed succes6i~ely with 10~ aqu~ous
~ 1~ hydrochloric acld (250 ml.) w~ter (2 x 250 ml.) and water saturated with
16 ~¦ sodium chloride (250 ml.). The ethereal solution W&s dried (Na2S04),
17 l¦ ~iltered, and the ~iltrate reduced to dryness to giYe (+)-5-cyclohexyl~
18 ¦ $ndancarboxylic acid (5.5 grams), m.p. 108 - llO~C. T~o recryst ~ l~ations
~ ~om petroleu~ ethor (~-p. 39 ~ 50~C-~,gave colorlass needles, m.~. 108 -
20lOg.gC~ C~]D5 ~ 9.60 (ethanol)~ and E~365 1 44.8 (cthanol).
21_ ~1. Calc'd. ~or C16~ 002: C~ 78.65; H~ ô- 5- ¦
22~ Found: C~ 78.40; H, 8.27.
23 1 ~

2S l B) (-)-5-CYclohQxYl-l-indancnrboxylic Acid:
26 The mother liguors from the ~alt ~ormation in 2art A, were reduced to
27 ~ dryness and the re~idue treated with ether and 10% aqueou3 hydrochloric
28 ¦ acid as ~re~iously de~cribed ~or the salt of the ~) lscmer and from the
29- ethereal l~yer wa~ obtained a partially resolved mixture o~ acids (7.6
gr~mu)~ enriched in~the (-) is er, ~a~D - 7.69' lethanol) and ~o~365 -


I -20-
'`' !l ' ' ' .' . ,- ' I





1038400
1 jl 35.4 (ethanol). m is mixture WQS extracted with boiling petroleum ether
(b.p. 39 - 50C., 3 x 35 ml.) and the combined extracts were reduced in
1,
3 l~ volume ~50 ml.) and cooled in an ice bath. The crystalline solid (5.1
~ ,, grams), m.p. 105 - 108~C., C~]D - 8.91- (ethanol) and [~]365 - 41.5
S ~! (eth~3nol)~ was collected.
6 1~ me solution of this acid (5.02 grams, 0.0205 mole) and dehydroabietyl-
7 ~I amine (5.85 grams, 0.0205 mole) in ethanol (500 ml.) was boiled down to a
~ olume of about 175~ml. and cooled to 25C. during two hours. me
9 !I dehydroabietylamine æalt of (-)-5-cyclohexyl-1-indancarboxylic acid (8.7
1I grams), m.p. 179 - 181C., was collected and recrystallized from ethanol
11 ¦I to giYe colorless crystals (8.o grams), m.p. 184 - 185C. me mother
12 !¦ llquors from the product with m.p. 179 - 181C., were reduced in Yol~me
13 1l and an addition~l crop of salt (0.95 gram), m.p. 178.5 - 180.5C., was I -
14 l~ isol~ted. This latter material was recrystPllized fro~ ethanol and the
product (o.78 gram), m.p. 182 - 183~C., w, combined with the main crop.
16 ¦i Ihe dehydroabietylamine salt (ô.78 grams) was partitioned between ether
17 !l (400 ml. ) and 10% aqueous hydrochloric acid. The ethereal solution was
18 ¦I washed with water (3 x 150 ml.) followed by water saturated with sodium
chlo~ide (2 x 100 ml.), dried (Na2S04j, and reduced to ~ryne3s to leave
I! the (-) isomer (4.0 grams). Recrysta~lization from petroleum ether
21 11 (b.p. 39 - 50C~ gave calorlesæ needle~ (3.41 grams) of (-)-5-cyclohexyl- ¦
22 ¦¦ l-indancarboxylic acid: m.p. 108 - ~09.5C., ~]D5 9.66 (ethanol) and
I ~]365 44 70 (ethanol)-

Anal. Calc d for CI6H2002: C, 78.65, ~, 8.25
D 1~ ~ Fcund: C, 78.B5~ H, 8 31


29 ! ~

,.,. : ':' ' ' '' ~
I -21- I
; ' ' ,1
.. . . . .
~ . . . .. ... . .. .. . ... . . . .

i



~oo `


3 l, Resolution of(+)-6-Chloro-5-Cyclohexyl~ dancarboxYlic Acid:
4 l'
S j, A) t+)-6-Chloro-5-cyclohexyl-1-indancarboxylic Acld
6 'I A solution 4~ (~)-6-chloro~5-cyclohexyl-1-indancarboxylic acid (20.0 g,
, 0.0719 ~ole) and dehydroabietylamine (10.22 g, 0.03595 mole~ in absolute
i ethanol (700 ml.) wa~ boiled down to a volume of about 380 ml. The mixture
- 9 'I was allowed to cool sloway a~d was left for 20 hours at sbout 25. The

1 10 !I resulting cryst~lline 301id (16.3 g.), m.p. 188 - 190C, *ns collected and I -
11 !! recrystallized ~rom methanol:water (20:1) to give colorless cryst ls (11.0 g.),
12 1! m.p. lg2 - 194C. ~ecrysta~l1zation from methanol gave colorless crystals
¦¦ (7.4 g.), m.p. 194 - 195.5C. The salt was partitioned between diethyl
~` 14 !¦ ether and 1 N hydrochloric acid. The ethereal layer was washed successi~ely
lS 1I with 1 N hydrochloric acid (twice), w~ter (twice), and water saturated with
16 1! sodium chloride. The ethereal solution was dried (Na2S ~ ) and concentrated
~ 1, 1! to give (+)-6-chloro-5-cyclohexyl-1-indancarboxylic acid (3.5 g.) as
¦ 18 1I colorless cryst~ls, m.p. 133 - 134C. Recryst~llization f~om Skelly~olve
19 ¦¦ ga~e colorless needles (3.0 g-), m.p. 135 - 136C, ~]D5 + 28.7 (ethanol)
¦l and ~vq365 + 88.7 (ethanol)-
¦ A~Sa1. CB1CId. for C16~19C102s C, 68.94; ~, 6.~7; Cl, 12.72
, Found: C, 68.94; H, 6.81; Cl, 12.64
23
24 B) (-)-6-Chloro-5-cyclohexyl-1-indancarboxylic Acid
2S ¦ A solution ~ (+)-5-cyclohexyl-1-indancarboxylic acid (8.o g., 0.0328
mole) and N-chlorosuccinimide (6.52 g., 0.049 ~ole) in dimethylformo~ide
1 27 I (66 ml.) wns hested, with stirring, by means o~ an oil bath maintained ~t
28 ~ 52 - 55C for 9 hours, ~ollcwed by 32 for 10 hour~. me solutlon WBS

¦ poured into water (280 ml.) and the mixture triturated w~th ~ce cooling.

30 1~
~i i
il -22-
~1 I

: . 't


'~ , .
--'~ ~ .

.' 1 `
i03B400
.
1 i The resulting solid was collected, dried, and recrystallized from
2 Skellysol~e B ~Norit) to gi~e colorless crystals (3.12 g., 34%), m.p. 127 -
3 ~ 130C. The product was recrystallized twice from petroleum ether (b.p. 30
4 I 60C) to giYe (-)-6-chloro-5-cyclohexyl-1-indancarboxylic acid as colorless
S ~i crystals, m.p. ~34 - 135C, ~c]D - 28.2 (ethanol) and ['J365 - 87.5
6 'I (ethanol).
7 Anal. Calc d. ~or C16HlgC102: C, 68-94; H, 6-87; Cl~ 12-72
8 ' ~ Found: C, 68.82; H, 6.86; Cl, 12.68

10 ~, Example 6
11 ii I
12 ~, (+~5 ~ ro-1-ind~ncarboxylic Acid
A mixture of concentrated sulfuric acid (670 g.) and concentrated
il nitric acid (~2.0 g. o~ 70~, o.466 le HN03) was added, dropwise with
stirring, to a cooled (ice-water) mixture of (~)-5-cyclohexyl-1-indancarboxylic
16 !¦ acid (100.0 g., 0.409 mole) in nitromethane (12So ml.) oYer a period of
17 11 70 minutes. The solution was then stirred for two hours with cooling,
18 I follcwed by 2.5 hours at 25. The reaction mixture was poured ~nto ice.
19 1! me resulting mixture wa~ extracted with diethyl ether. me ether extract
~¦ was washed with water, followed by aqueous sodium acetate, water, and
21 ~I saturatad aqueous sodium chloride. Ihe ether solution was then dried
22 ¦ (Na2S ~ ) and concentrated. Ihe residue was crystallized from nitromethane
23 ¦~ to giYe a tsn solid (48.7 g.), m.p. loe - 112C. Recrystallization ~rom
24 1l benzene:SkellysolYe B gave tan crystals`, m.p. 112 - 115C.
¦¦ A portion of the product was purif,~ed by chromatography on silicic
26 ll acid (Mallinckrodt CC-4, 100-200 mesh) ~ith toluene:acetone (30:1). The
27 'I product was finally recryst~l~ized fro~jbenzene:Skellysol~e ~ to giYe
28 ~ )5-cyclohexyl-6-nitro-1-indancsrboxylic acid ~s pale ye Uow crystal6,
29 11 m.p. 118 - 120C, resolidifying and rem~lting at 150 - 151C.
30 1~* "Norit" i8 a trade mark for activatej adsorptlon carbons of vegetable
'~ brigin.
j - -23- ~ `

~r '.
Ij
` !
'I 1038400
!l
1 1~Anal. Calc'd. ~or C16~ 9N04: C, 66-42;-H, 6-62; N~ 4-84 .!
2 ~ound: C, 66.75; H, 6.72; N, 4.67
, 3 ',
., ~; . .
4 I Example 7
I,
6 ~ Amino-5-cyclohexyl-indancarboxylic Acid
7 il- ~ solution o~ t~)5-cyclohexyl,6-nitro-1-indancarboxylic acid (14.0 g.)
in 95~ ethanol (200 ml.) containing Raney ~ickel was shaken with hydrogen
9 11 at room temperature and an initial pressure of 3.5 ~g./cm2 for 2.5 hours.
¦l The catalyst WAS removed by filtration and the filtrate concentratet to
11 I; about half ~olume by boiling. After addition of a small volume of water
12 !¦ to the hot solution, the (+)-6-amino-5-cyclohexyl-1-inda~carboxylic acid (8.9 8?
13 ¦I crystallized as light green crystals, m.p. 103 - 114C.
14
lS ¦l : . ExamPle 8
16 ,~
17 l¦ (* ~-Cyclohexyl-6-hydroxy-1-indancarboxylic Acid
18 I A mixture (~)6-amino-5-cyclohexyl-1-indancarhoxylic acid (5.80 g.,
19 1, o.oz24 mole), water (50 ml.) and concentrated hydrochloric acid (50 ml.)
¦ was cooled to 0 and treated, with stirring7 over a period o~ 45 minutes
21 !¦ with sodium nitrite (1.70 g., 0.0246 mole) in water (5 ml.). Stirring was
l; continued for 15 minu,tes at 25, followed by 8 minutes at 80 - 90. The
24 ! mixture was cooled and extracted with diethyl ether. The ether solution
¦ was washed twice w~th water ~ollowed by saturated aqueous sodi~m chloride~
~ a~d concentrated in ~ rotary evaporator. The residual gum was purified by
~¦ chromatography on silicic acid (110 g. of Mallinckrodt CC-4, 100-200 mesh)
¦ with toluene:acetone (20:1). The product was recrystallized from benze~e:
11 Skellysolve B to giYe tan cryst~ls (2.0 g.) m.p. 159 - 160. The product
¦¦ wa~ recrystallizea twice from benzene:SXellysol~e B to give (+)5-cyclohexyl-

6-hydroxy-1-indanc~rb~xylic acid a~ tan crystals, m.p. 159.5 - 161.
1~ ' 1
-24- -
'' ' 1~ ' , . ,


;,
,, ' '' I~'' ' ' , ', ~
~ . 1038400
i, Anal. Calc'd for C16H2003: C, 73-82; ~, 7-74
2 li Found: C9 74.00; ~H, 7.99

ample 9
~ s !i .
6 '' (+)~-Cyclohexyl-6-metho~ 1ndancarboxyllc Acid
Ii
7 'I A mixture Or (+)-5-cyclohexy1-6-hydroxy-1-indancarbox;ylic acid (~.oe g.,
8 Il 0.0154 mole), dimethyl sulfate (4.29 g., 0.034 mole), and potassium carbonate
9 li (8.55 g., 0.0618 mole) in acetone (45 ml.) containing 10,~ potassium hydroxide
!1 in methanol (1 ml.) was heated under reflux for four hours and was then ,
11 ~i a~lowed to stand at 25 for 17 hours. The mixture was filtered and 'che
12 ~l ~iltrate concentrated in a rotary evaporator. me resldual red oll (5.6 g.)
U ¦! was purified by chromatography on silicic acid (160 g. of Ma~linckrodt CC-7,
14 ¦~ 100-200 mesh~ with toluene.
I¦ A mixture of the yellow oil (3.3 g.) obtained ~rom chromatography, 1
16 1¦ NaOH (25 ml-)? and 95% ethanol (6 ml.) was heated under reflux ~or 35
17 ~ inutes. The cooled solution was acidi~ied with dilute hydrochloric acid. I
18 ! The precipitated crystalline solid (2.93 g.) m.p. 162 ~ 1~4, was recrystall-, ;;-
19 ¦! ized from cyclobexane to give (~)5-cyclohexyl-6-methoxy-1-indancarboxylic j
20 1¦ acid (2.72 g.) as ~ale yellow crystals~ m.p. 167.5 - 16go.
21 liAnal. C~c'd. ror C17H2203 C, 74-42; H, 8.08
I! ~otmd: C, 74.63; H, 8.28
23 1~ i
24 1 . ' ~ le 10
,- 2S j . " ' '. -
26 l (+~ rclohexyl-6-fluoro-1-indancarbox~rlic Acid
,
27 ¦ A suspension of (~6-amino-5-cyclohexyl-1-indanc~boxylic acid
28 1¦ (lO.0 g.~ o.o386 le) in dieth~l ether (70 ml.) wa~ treated with an excess
29 ¦¦ of ethereal diazomethalle. me solution was filtered and t~e filtrate
30 1! concentrated on a steam bath to ~ilre the meth~rl ester as an oil.
,!
25-

- !l

.




'~~ 103~3400
1 Fluoroboric acid (21.0 g., 0.116 mole) was added to a solution of the2 , ester in ethanol (10 ml.). To the cooled (ice-water) solution was added,3 I with stirring, isoamyl nitrite (5.0 g., 0.0~25 mole) over a period of two
4 1I minutes. me ~ixkure was allowed to stand at 0 for 0.5 hours. The
S `I solution was then diluted with diethyl 2ther (150 ml.) and kept at -10~ for
6 ,, 20 hours. The solid diazonium fluoroborate (9.0 g.) was collected and dried.
7 ,, A suspension of the diszonium salt in Skellysol~e C~(100 ml.) was heated
1' under reflux for 0.5 hours. The mixture was ~iltered while still wsrm and the1l ;
9 !¦ ~iltrate concentrated to give methyl (~)5-cyclohexyl-6-fluoro-1-indancarboxy- !
¦I late (6.2 g.),
11 li A mixture of the crude ester (6.2 g.), 1 N sodium hydroxide (50 ml.),
12 !~ and 95~ ethanol (20 ml.) was heated under reflux for 0.5 hour. The hot
solution was treated with Norit and filtered. The cooled filtrate was ~,
14 ~ scidified with 1 N- hydrochloric acid and the precipitated material extrscted j
1! into diethyl ether. The ether solution was washed twice with water followed
16 ' by saturated aqueous sodium chloride, and dried (Na2S04). The dried solution !
17 I~ was reduced to dryness and the residue recrystallized from Skellysol~e B to
il
gi~e pale yellow crystals (4.4 g.), m.p. 137 - 141. The product was purified1
by chromatography on silicic acid (Mallinckrodt CC-4, 100-200 mesh) with
~ toluene:acetone (25:1), and finslly recrystallized from aqueous ethanol to
21 ~¦ give (_)5-cyclohexy1-6-fluoro-1-indancarboxylic acid (3.5 g.) as pale yellow
22 1I crystals, m.p. 143 -,145.5 .
23'! Anal. Calc'd. for C~6HlgF42 C, 73.26; H, 7.30
241¦ Found: C, 72.99; H, 7.40
25 i!
26 1!
27 li
: 28
:-. ij ' ' ''
2g 1,

!
-26- - ,
. I .1
! , . . .



1l l03s~ao~ I
1 5 Example 11
' 2 ~i ,
3 l,
4 l, (+)-Methyl 5-Cyclohexyl-l-indancarboxylate
S ,I Excess diazomethane in diethyl ether was added to a su3pension of
i; 6 ~l (+)-5-cyclohexyl-1-indancarboxylic acid (lô.0 g) in diethyl ether (100 ml.).
7 i¦ qhe resulting solution was concentrated to an oil which slowly crystallized
1 8 1i¦ on standing'to g$ve a buff solid (19.5 g.), m.p. 44.5 - 46.5. The product
'; 9 ¦I was recrystallized from'methanol (Norit) to gi~e colorless crystals (18.2 g.) '
l¦ m.p. 46.5 - 48. ,
, 11 '1l Anal. Calc'd. ror C17~22 C, 79.03; H, ô-58
12 1¦ ~ound: C, 78.ôô; N, 8.74
' .13 11 " , , I
.~ 14 1i j :
., lS 11 ,, . 1., .
,,' 16 ~3 ` Ex~mple 12,
' 17
, ~, 18 !¦ ! -
,-' ll (-)-Methyl 5-Cyclohexyl-l-indancarboxylate
~I Excess diazomethane in diethyl ether was added to an ~ce-cold sol~t~on

- 1~ Or (-)-5-cyclohexyl~1-indancarboxylic acid (6.o g.) in diethyl ether
Il (50 ml.). me solution was filtered snd concentrated to 75 ~1. The
24 ¦ solution wa6 ~ashed with saturated aqueous sodium bicarbonate follcwed by

2S water and saturated ~ueous 60dium chloride, dried ,(Na2S04), and concentrated
26 '~ in a rotary evaporator. The residual oil wa6 di~tilled to gi~e (-)-methyl
¦ 5-cyclohexyl-1-indancsrboxylate (5.6 g.) as a colorle6s oil~ b.p. 14p - 150

28 1 (0.1 m~), [~]D ~ -93 (benzene), and ~365'- 12.4- (benzene).
29 1 A~ 1. Calc'd ~or C17H2202 C~ 79 ,3;
¦ Found: C, 78.97; H, 8.ô5
, 11 ' , . .. I
~ 27- 1

~ !'
-~ .
-~r~, . . . ...
' . ' .

!! . ,
.~
i' . . 1038~00 ,
l iI Example 13

. . .
3 ~;
Ethyl 5-Cyclohexyl-l-indancarboxylate ~ -
~ .
, 1
: 5 ;' A solution of(~)-5-cyclohexyl-1-indancarbcxylic acid (6.o g. ) in ethanol I
6 '1 (30 ml.) containing hydrogen chloride (9.0 g.) was heated under reflux for
; 1l 4.5 hours. 'I'he cooled solution was diluted with water, and the ethanol
3 ~~ re ved in a rotary e~aporator. me residual aqueous mixture was extracted
9 1, with diethyl ether. ~'he ether extract was washed with aqueous sodium
,! bicarbonate followed by water and saturated aqueous sodium chloride, dried
(Na2S04), and concentrated. The residual oil was distilled to gi~e (+)-ethyl ~
12 ¦l 5-cyclohexyl-1-indancarboxylate (5.1 g.) as a colorless oil, b.p. 141.5 - ¦
13 il 142 (O.oe mm).
i 1~ 1!An~l. Calc'd rOr C18~ 402: C, 79-37; H, 8-88
~` lS 1l Found: C, 79.67; H, 8.94
16 ll
j
17 !1
!i
~. 18 11 !
" . ..
19 ! ample l4
20 il j
21
22 ~ )-N-Methyl-4-piperidyl 5-Cyclohexyl-l-indancarboxylate Hydrochloride
23 1!A solution o~ (~)-5-cyclohexyl-1-indancarboxylic acid (7.0 g., 0.0284
24 1¦mole), thionyl chloride (3.5 g., 0.0294 mole), ~nd dimet4ylformamide (3 drops)j
2S i in methylene chloride (75 ml.) was heated under reflux Por one hour. me

26 solution was concentrated in a rotary evaporator. A solution of the residual ¦
27 l¦ oil in benzene (20 ml.) was ~dded dropwise, with cooling, to a solution of -
28 l¦ 4-hydroxy-N-mRthylpiperidine (6.6 B., 0.0573 mole) ~n benzene (30 ml.) o~er
¦ a period of ten minut~s. The mixture was stirred at room temperature for
i an add~tlonal 15 mlnutes. Water (25 ml.) ~ollowed by catura~ed aqueou3
. '-
¦ -2a-
!
.


.j ~
- 10384()0

1 ~i sodium bicarbonate (50 ml.) was added to the mixture, which was stirred for
15 minutes. me ~enzene layer was separated, wsshed twice with water~
3 ~ dried (Na~S~ ), and concentrated to an orange oil ~9.4 g.). Hydrogen chloride,
4 ,j gas was p~ssed into a solution of the oil in diethyl ether tlOO mi.) until
S 1I no further material precipitated from solution. The supernatant ether was
6 ,I decanted, and the residual gum washed with fresh ether and then triturated
7 l) with ether acetate to give a crystalline solid (8.5 g.), m.p. 203 - 206.
8 !j me product was recrystallized from nitromethane (Norit) to give (~)-N-
9 ¦¦ methyl-4-piperidyl 5-cyclohexyl-l~indancarboxylate hydrochloride as an off-
. ~
~ I0 llwhite solid, m.p. 207 - 210.
; 11 ilAnP~. Calc'd ~or C22H31N02 HCl: C, 69-90; H~ 8-54; Cl~ 9-38; N~ 3-71
12 ¦¦~ound: C~ 69.93; H, 8.65; Cl, 9.25; N, 3.88
. 13

ls 11 I
16 ¦ Exam~le 15
17
18
19 11 (+) ~ Dimethylaminoethyl 5-Cy~lohexyl-l-indancarboxylate ~drochloride20 ¦ In a manner 8imi1&r t~ that described in Example 14~ dimethylsmino~
21 j ethyl 5-cyclohexyl~l-lndancsrbcxylate hydroc,~loride was prepared from
22 ~ 5-cyclohexyl-1-indancarboxylic acld (r.o g., 0.~284 mole), thionyl
23 ¦ chloride (3.5 g., o.oes4 mole), ~-dimethylaminoethanol (5.1 g., 0.0573 mole) i
24 ¦¦ and hydrogen chlorlde. The crude hydrochloride (8.7 ~.) was recry8tal11zed
2S !¦ ~rom ethyl ~cetate to gi~e off-white crystals, m.p. 14~3 - 150.
26 llAn 1. Calc'd ~or C20~29N02 HCl: C, 68.25; H~ 8.59; N, 3.63
27 l. Found: C~ 67.90; H, 8.76; N~ 3.85
28


I~. -29- -
, !

Representative Drawing

Sorry, the representative drawing for patent document number 1038400 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1978-09-12
(45) Issued 1978-09-12
Expired 1995-09-12

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BRISTOL-MYERS SQUIBB COMPANY
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1994-05-19 1 8
Claims 1994-05-19 4 98
Abstract 1994-05-19 1 25
Cover Page 1994-05-19 1 24
Description 1994-05-19 32 1,413